NanoViricides
NNVC
35 hedge funds and large institutions have $2.04M invested in NanoViricides in 2025 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 5 closing their positions.
40% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 5
20% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 5
9% more capital invested
Capital invested by funds: $1.87M → $2.04M (+$175K)
6% more funds holding
Funds holding: 33 → 35 (+2)
0.58% more ownership
Funds ownership: 8.31% → 8.89% (+0.58%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$148K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$142K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$78.2K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$25.1K |
| 5 |
TPWA
TRUE Private Wealth Advisors
Salem,
Oregon
|
+$15K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$135K |
| 2 |
VF
Virtu Financial
New York
|
-$69K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$43K |
| 4 |
XT
XTX Topco
George Town,
Cayman Islands
|
-$15.5K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$12K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
TRCT
26
Tower Research Capital (TRC)
New York
| $1.18K | +$1.23K | +823 | New |
|
|
BWM
27
Bernard Wealth Management
Royal Oak,
Michigan
| $715 | – | – | – |
|
|
SS
28
SBI Securities
Tokyo,
Japan
| $429 | – | – | – |
|
|
CA
29
Clearstead Advisors
Cleveland,
Ohio
| $419 | – | – | – |
|
|
AUB
30
Atlantic Union Bankshares
Glen Allen,
Virginia
| $379 | – | – | – |
|
|
TWC
31
TD Waterhouse Canada
Toronto,
Ontario, Canada
| $376 | – | – | – |
|
32
Bank of America
Charlotte,
North Carolina
| $352 | -$9 | -6 | -2% |
|
33
US Bancorp
Minneapolis,
Minnesota
| $61 | – | – | – |
|
34
Fidelity Investments
Boston,
Massachusetts
| $51 | – | – | – |
|
35
JP Morgan Chase
New York
| $49 | +$1 | +1 | +3% |
|
|
VF
36
Virtu Financial
New York
| – | -$69K | -49,235 | Closed |
|
|
37
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$43K | -30,535 | Closed |
|
38
Wells Fargo
San Francisco,
California
| – | -$1.4K | -1,000 | Closed |
|
39
Raymond James Financial
St Petersburg,
Florida
| – | -$62 | -44 | Closed |
|
|
HI
40
Harbour Investments
Madison,
Wisconsin
| – | -$35 | -25 | Closed |
|
NNVC Hedge Fund Activity: Q3 2025 in Review
35 of the 7,621 institutional investors tracked by Wall St. Rank reported a position in NanoViricides (NNVC) for Q3 2025, worth a combined $2.04M — up 9.4% from $1.87M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new NNVC positions and 5 closed out — a net gain of 2 holders — while 6 added to existing stakes and 5 trimmed.
The largest buyer was Renaissance Technologies, adding an estimated $148K. The largest seller was UBS Group, cutting an estimated $135K.
- 35 institutional investors held NanoViricides (NNVC) as of Q3 2025, up from 33 in Q2 2025.
- Funds reported $2.04M of NanoViricides stock for Q3 2025, up 9.4% quarter-over-quarter.
- 7 funds opened new NanoViricides positions in Q3 2025 and 5 closed out, a net change of +2 holders.
- The largest NanoViricides buyer in Q3 2025 was Renaissance Technologies, an estimated $148K added.
- The largest NanoViricides seller in Q3 2025 was UBS Group, an estimated $135K sold.
Based on aggregated 13F filings for Q3 2025.